Works matching AU Verbeke, Geert

Results: 164
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17

    Correction to: A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trial.

    Published in:
    2020
    By:
    • Devos, Timothy;
    • Geukens, Tatjana;
    • Schauwvlieghe, Alexander;
    • Ariën, Kevin K.;
    • Barbezange, Cyril;
    • Cleeren, Myriam;
    • Compernolle, Veerle;
    • Dauby, Nicolas;
    • Desmecht, Daniël;
    • Grimaldi, David;
    • Lambrecht, Bart N.;
    • Luyten, Anne;
    • Maes, Piet;
    • Moutschen, Michel;
    • Romano, Marta;
    • Seyler, Lucie;
    • Nevessignsky, Michel Toungouz;
    • Vandenberghe, Katleen;
    • van Griensven, Johan;
    • Verbeke, Geert
    Publication type:
    corrected article
    18

    A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trial

    Published in:
    Trials, 2020, v. 21, n. 1, p. 1, doi. 10.1186/s13063-020-04876-0
    By:
    • Devos, Timothy;
    • Geukens, Tatjana;
    • Schauwvlieghe, Alexander;
    • Ariën, Kevin K.;
    • Barbezange, Cyril;
    • Cleeren, Myriam;
    • Compernolle, Veerle;
    • Dauby, Nicolas;
    • Desmecht, Daniël;
    • Grimaldi, David;
    • Lambrecht, Bart N.;
    • Luyten, Anne;
    • Maes, Piet;
    • Moutschen, Michel;
    • Romano, Marta;
    • Seyler, Lucie;
    • Nevessignsky, Michel Toungouz;
    • Vandenberghe, Katleen;
    • van Griensven, Johan;
    • Verbeke, Geert
    Publication type:
    Article
    19

    A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trial.

    Published in:
    Trials, 2020, v. 21, n. 1, p. N.PAG, doi. 10.1186/s13063-020-04876-0
    By:
    • Devos, Timothy;
    • Geukens, Tatjana;
    • Schauvlieghe, Alexander;
    • Ariën, Kevin K.;
    • Barbezange, Cyril;
    • Cleeren, Myriam;
    • Compernolle, Veerle;
    • Dauby, Nicolas;
    • Desmecht, Daniël;
    • Grimaldi, David;
    • Lambrecht, Bart N.;
    • Luyten, Anne;
    • Maes, Piet;
    • Moutschen, Michel;
    • Romano, Marta;
    • Seyler, Lucie;
    • Nevessignsky, Michel Toungouz;
    • Vandenberghe, Katleen;
    • van Griensven, Johan;
    • Verbeke, Geert
    Publication type:
    Article
    20
    21
    22
    23
    24
    25
    26
    27

    Gene Filtering in the Analysis of Illumina Microarray Experiments.

    Published in:
    Statistical Applications in Genetics & Molecular Biology, 2012, v. 11, n. 2, p. 1, doi. 10.2202/1544-6115.1710
    By:
    • Forcheh, Anyiawung Chiara;
    • Verbeke, Geert;
    • Kasim, Adetayo;
    • Lin, Dan;
    • Shkedy, Ziv;
    • Talloen, Willem;
    • Göhlmann, Hinrich W. H.;
    • Clement, Lieven
    Publication type:
    Article
    28
    29
    30
    31
    32
    33

    Report of the Editors-2010.

    Published in:
    2011
    By:
    • Louis, Thomas A.;
    • Millar, Russell;
    • Verbeke, Geert;
    • Zucker, David;
    • Davidian, Marie
    Publication type:
    Editorial
    34
    35
    36

    Report of the Editors—2009.

    Published in:
    Biometrics, 2010, v. 66, n. 1, p. vii, doi. 10.1111/j.1541-0420.2009.01394.x
    By:
    • Louis, Thomas A.;
    • Molenberghs, Geert;
    • Verbeke, Geert;
    • Zucker, David;
    • Davidian, Marie
    Publication type:
    Article
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47

    Sensitivity Analysis for Pattern Mixture Models.

    Published in:
    Journal of Biopharmaceutical Statistics, 2004, v. 14, n. 1, p. 125, doi. 10.1081/BIP-120028510
    By:
    • Curran, Desmond;
    • Molenberghs, Geert;
    • Thijs, Herbert;
    • Verbeke, Geert
    Publication type:
    Article
    48
    49
    50